ask="1.150"
ask_size="200"
average_daily_volume="850972"
bid="1.100"
bid_size="1000"
book_value="1.373"
change="+0.025"
change_from_200_day_moving_average="-1.426"
change_from_50_day_moving_average="-0.394"
change_from_52_week_high="-7.775"
change_From_52_week_low="0.185"
change_in_percent="+2.273%"
close="1.125"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.310"
ebitda="-61.52M"
eps_estimate_current_year="-1.330"
eps_estimate_next_quarter="-0.370"
eps_estimate_next_year="-1.420"
ex_dividend_date="N/A"
float_shares="36930000"
high="1.150"
high_52_weeks="8.900"
last_trade_date="3/6/2017"
last_trade_price="1.125"
last_trade_size="7952"
last_trade_time="4:00pm"
low="1.050"
low_52_weeks="0.940"
market_capitalization="59.54M"
moving_average_200_day="2.551"
moving_average_50_day="1.519"
name="Regulus Therapeutics Inc."
notes="N/A"
one_year_target_price="7.000"
open="1.100"
pe_ratio="N/A"
peg_ratio="-0.020"
percent_change_from_200_day_moving_average="-55.901%"
percent_change_from_50_day_moving_average="-25.944%"
percent_change_from_52_week_high="-87.360%"
percent_change_from_52_week_low="+19.681%"
previous_close="1.100"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.801"
price_per_sales="4.837"
revenue="12.04M"
shares_outstanding="52923000"
short_ratio="3.470"
stock_exchange="NGM"
symbol="RGLS"
volume="436784"
weeks_range_52="0.940 - 8.900"
